A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
The researchers are doing this study to find out whether elacestrant is an effective and safe treatment alone or in combination with abemaciclib for people with advanced or recurrent ER+ endometrial cancer.
Epistemonikos ID: 5ee4138be792ece4585e98d9c3fc6334d4c0d87e
First added on: Oct 08, 2025